ATE334223T1 - Verfahren zur herstellung eines rekombinanten polypeptids unter hinzufügung eines hemmstoffes einer metallabhängigen protease oder chymotrypsins zum zellkulturmedium - Google Patents
Verfahren zur herstellung eines rekombinanten polypeptids unter hinzufügung eines hemmstoffes einer metallabhängigen protease oder chymotrypsins zum zellkulturmediumInfo
- Publication number
- ATE334223T1 ATE334223T1 AT97923382T AT97923382T ATE334223T1 AT E334223 T1 ATE334223 T1 AT E334223T1 AT 97923382 T AT97923382 T AT 97923382T AT 97923382 T AT97923382 T AT 97923382T AT E334223 T1 ATE334223 T1 AT E334223T1
- Authority
- AT
- Austria
- Prior art keywords
- cell culture
- culture medium
- metal
- chymotrypsin
- producing
- Prior art date
Links
- 239000006143 cell culture medium Substances 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 229920001184 polypeptide Polymers 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- CFYIUBWVKZQDOG-UHFFFAOYSA-N 4-[[2-[[2-[[1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]amino]-2-oxoethyl]amino]-4-oxobutanoic acid Chemical compound C=1C=C([N+]([O-])=O)C=CC=1NC(=O)C(NC(=O)CNC(=O)CNC(=O)CCC(=O)O)CC1=CC=CC=C1 CFYIUBWVKZQDOG-UHFFFAOYSA-N 0.000 title 1
- 108090000317 Chymotrypsin Proteins 0.000 title 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 title 1
- 229960002376 chymotrypsin Drugs 0.000 title 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title 1
- 102000035195 Peptidases Human genes 0.000 abstract 3
- 108091005804 Peptidases Proteins 0.000 abstract 3
- 239000004365 Protease Substances 0.000 abstract 3
- 102100026735 Coagulation factor VIII Human genes 0.000 abstract 2
- 108010054218 Factor VIII Proteins 0.000 abstract 2
- 102000001690 Factor VIII Human genes 0.000 abstract 2
- 201000003542 Factor VIII deficiency Diseases 0.000 abstract 2
- 208000009292 Hemophilia A Diseases 0.000 abstract 2
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 abstract 2
- 230000001419 dependent effect Effects 0.000 abstract 2
- 229960000301 factor viii Drugs 0.000 abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 2
- 239000002184 metal Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 108090000144 Human Proteins Proteins 0.000 abstract 1
- 102000003839 Human Proteins Human genes 0.000 abstract 1
- 238000004113 cell culture Methods 0.000 abstract 1
- 230000001627 detrimental effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000003248 secreting effect Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Plant Pathology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9601855A SE9601855D0 (sv) | 1996-05-14 | 1996-05-14 | Process for producing a protein |
| US1887496P | 1996-05-29 | 1996-05-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE334223T1 true ATE334223T1 (de) | 2006-08-15 |
Family
ID=26662616
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03000391T ATE321141T1 (de) | 1996-05-14 | 1997-05-13 | Verfahren zur herstellung eines rekombinanten polypeptids unter hinzufügung eines chymotrypsinhemmstoffes zum zellkulturmedium |
| AT97923382T ATE334223T1 (de) | 1996-05-14 | 1997-05-13 | Verfahren zur herstellung eines rekombinanten polypeptids unter hinzufügung eines hemmstoffes einer metallabhängigen protease oder chymotrypsins zum zellkulturmedium |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03000391T ATE321141T1 (de) | 1996-05-14 | 1997-05-13 | Verfahren zur herstellung eines rekombinanten polypeptids unter hinzufügung eines chymotrypsinhemmstoffes zum zellkulturmedium |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5851800A (de) |
| EP (1) | EP0934424B1 (de) |
| JP (2) | JP2000509994A (de) |
| AT (2) | ATE321141T1 (de) |
| AU (1) | AU716245B2 (de) |
| CA (1) | CA2253287C (de) |
| DE (2) | DE69735510T2 (de) |
| DK (1) | DK0934424T3 (de) |
| ES (2) | ES2270460T3 (de) |
| NO (2) | NO325358B1 (de) |
| NZ (1) | NZ332751A (de) |
| PT (2) | PT1318198E (de) |
| WO (1) | WO1997043436A1 (de) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6475725B1 (en) * | 1997-06-20 | 2002-11-05 | Baxter Aktiengesellschaft | Recombinant cell clones having increased stability and methods of making and using the same |
| EP2921180B1 (de) | 1999-02-22 | 2019-08-14 | University of Connecticut | Albuminfreie Faktor-VIII-Formulierungen |
| AT409379B (de) | 1999-06-02 | 2002-07-25 | Baxter Ag | Medium zur protein- und serumfreien kultivierung von zellen |
| ATE330003T1 (de) * | 1999-08-05 | 2006-07-15 | Baxter Ag | Rekombinanter stabiler zellklon, seine herstellung und verwendung |
| WO2001052891A1 (fr) * | 2000-01-20 | 2001-07-26 | Nippon Organon K. K. | Inhibiteurs d'invasion plasmodiale dans des erythrocytes |
| PT2287288E (pt) * | 2002-07-09 | 2012-12-10 | Baxter Int | Meio isento de proteína animal para cultura de células |
| CN101857851A (zh) * | 2002-12-23 | 2010-10-13 | 布里斯托尔-迈尔斯斯奎布公司 | 用于蛋白质生产的哺乳动物细胞培养方法 |
| DE60335024D1 (de) * | 2002-12-23 | 2010-12-30 | Bristol Myers Squibb Co | Produktqualitätsverbesserung in säugerzellkulturverfahrenzur proteinproduktion |
| US20040265964A1 (en) * | 2003-04-25 | 2004-12-30 | Martin Allen | Inducers of recombinant protein expression |
| US7255288B2 (en) * | 2004-03-08 | 2007-08-14 | Wan Shan Chan | Aroma therapy for fountain |
| US20060094104A1 (en) * | 2004-10-29 | 2006-05-04 | Leopold Grillberger | Animal protein-free media for cultivation of cells |
| EP1707634A1 (de) * | 2005-03-29 | 2006-10-04 | Octapharma AG | Verfahren zur Isolierung von rekombinant hergestellten Proteinen |
| EP3653699A1 (de) | 2006-01-04 | 2020-05-20 | Baxalta Incorporated | Oligopeptidfreie zellkulturmedien |
| LT2126106T (lt) | 2007-02-23 | 2018-01-10 | Sk Chemicals Co., Ltd. | Viii faktoriaus ir jo darinių gavimo ir gryninimo būdas |
| EP1988101A1 (de) | 2007-05-04 | 2008-11-05 | Novo Nordisk A/S | Verbesserung von Faktor-VIII-Polypeptid-Titern in Zellkulturen |
| WO2008135498A2 (en) * | 2007-05-04 | 2008-11-13 | Novo Nordisk A/S | Prevention of protein degradation in mammalian cell cultures |
| NZ593190A (en) | 2008-11-07 | 2013-01-25 | Baxter Int | Factor viii formulations |
| US9540426B2 (en) | 2009-10-06 | 2017-01-10 | Bristol-Myers Squibb Company | Mammalian cell culture processes for protein production |
| CN107190034A (zh) | 2010-10-05 | 2017-09-22 | 诺沃—诺迪斯克保健股份有限公司 | 生产蛋白质的方法 |
| EP2906683B1 (de) | 2012-10-15 | 2017-05-31 | Bristol-Myers Squibb Company | Säugerzellkulturverfahren zur proteinproduktion |
| KR102668200B1 (ko) | 2015-10-28 | 2024-05-23 | 주식회사유한양행 | 지속형 fgf21 융합 단백질 및 이를 포함하는 약학적 조성물 |
| KR102670157B1 (ko) | 2015-10-28 | 2024-05-29 | 주식회사유한양행 | 이중 작용 단백질 및 이를 포함하는 약학적 조성물 |
| AU2017358289C1 (en) | 2016-11-10 | 2025-05-08 | Yuhan Corporation | Pharmaceutical composition for preventing or treating hepatitis, hepatic fibrosis, and hepatic cirrhosis comprising fusion proteins |
| CN110709520B (zh) | 2017-04-21 | 2024-04-05 | 株式会社柳韩洋行 | 用于产生双功能蛋白质及其衍生物的方法 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5149787A (en) * | 1984-05-22 | 1992-09-22 | The Blood Center Research Foundation | Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing |
| SE8501050D0 (sv) * | 1985-03-05 | 1985-03-05 | Kabivitrum Ab | Biologically active fragments of human antihemophilic factor and method for preparation thereof |
| US5279939A (en) * | 1986-08-18 | 1994-01-18 | Smithkline Beecham Corporation | Protein protease inhibitors from streptomyces |
| US4891356A (en) * | 1987-07-15 | 1990-01-02 | Brigham & Women's Hospital | Proteinase inhibitors for treatment of gastrointestinal ulcer disease |
| JPH0387173A (ja) * | 1987-09-10 | 1991-04-11 | Teijin Ltd | ヒト活性化天然型ファクター８ｃの製造方法及びそれに用いる形質転換体 |
| CA1340740C (en) * | 1987-12-08 | 1999-09-14 | Eileen R. Mulvihill | Co-expression in eukaryotic cells |
| JP2769170B2 (ja) * | 1987-12-08 | 1998-06-25 | ザイモジェネティクス，インコーポレイティド | 真核細肪中での同時発現 |
| DK457788D0 (da) * | 1988-08-16 | 1988-08-16 | Nordisk Gentofte | Fremgangsmaade til fremstilling af et oensket polypeptid |
| WO1990002175A1 (en) * | 1988-08-16 | 1990-03-08 | Novo Nordisk A/S | A method of producing polypeptides by culturing eukaryotic cells in the presence of protease inhibitors |
| GB8827305D0 (en) * | 1988-11-23 | 1988-12-29 | British Bio Technology | Compounds |
| DK105489D0 (da) * | 1989-03-03 | 1989-03-03 | Novo Nordisk As | Polypeptid |
| SE465222C5 (sv) * | 1989-12-15 | 1998-02-10 | Pharmacia & Upjohn Ab | Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning |
| DE69133064T2 (de) * | 1990-02-26 | 2003-03-06 | The Board Of Trustees Of The Leland Stanford Junior University, Stanford | Identifizierung und expression von insekten-steroidrezeptor-dns-sequenzen |
| US5189178A (en) * | 1990-11-21 | 1993-02-23 | Galardy Richard E | Matrix metalloprotease inhibitors |
| US5304603A (en) * | 1991-06-18 | 1994-04-19 | The Population Council | Leydig cell stimulator |
| US5661034A (en) * | 1991-07-18 | 1997-08-26 | Fuji Yakuhin Kogyo Kabushiki Kaisha | Serum-free medium for tissue culture containing tissue inhibitor of metalloproteinases and method for growing cells using the medium |
| WO1993006217A1 (en) * | 1991-09-19 | 1993-04-01 | Genentech, Inc. | EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab')2 ANTIBODIES |
| CA2078721A1 (en) * | 1991-09-24 | 1993-03-25 | Hiroshi Yonemura | Process for preparing human coagulation factor viii protein complex |
| US5278289A (en) * | 1991-11-12 | 1994-01-11 | Johnson Alan J | Antihemophilic factor stabilization |
| US5296471A (en) * | 1992-12-22 | 1994-03-22 | Glycomed Incorporated | Method for controlling o-desulfation of heparin and compositions produced thereby |
| WO1995005477A1 (en) * | 1993-08-12 | 1995-02-23 | University Of Maryland | Thermostable alkaline metalloprotease produced by a hyphomonas, and preparation thereof |
| US5631159A (en) * | 1993-09-22 | 1997-05-20 | Creative Biomolecules, Inc. | Lipid-modified serum free media |
| US5543396A (en) * | 1994-04-28 | 1996-08-06 | Georgia Tech Research Corp. | Proline phosphonate derivatives |
-
1997
- 1997-05-07 US US08/852,783 patent/US5851800A/en not_active Expired - Lifetime
- 1997-05-13 JP JP09540800A patent/JP2000509994A/ja active Pending
- 1997-05-13 DE DE69735510T patent/DE69735510T2/de not_active Expired - Lifetime
- 1997-05-13 WO PCT/SE1997/000783 patent/WO1997043436A1/en not_active Ceased
- 1997-05-13 AT AT03000391T patent/ATE321141T1/de active
- 1997-05-13 NZ NZ332751A patent/NZ332751A/en not_active IP Right Cessation
- 1997-05-13 AT AT97923382T patent/ATE334223T1/de active
- 1997-05-13 AU AU29197/97A patent/AU716245B2/en not_active Ceased
- 1997-05-13 PT PT03000391T patent/PT1318198E/pt unknown
- 1997-05-13 DK DK97923382T patent/DK0934424T3/da active
- 1997-05-13 EP EP97923382A patent/EP0934424B1/de not_active Expired - Lifetime
- 1997-05-13 PT PT97923382T patent/PT934424E/pt unknown
- 1997-05-13 CA CA002253287A patent/CA2253287C/en not_active Expired - Fee Related
- 1997-05-13 DE DE69736391T patent/DE69736391T2/de not_active Expired - Lifetime
- 1997-05-13 ES ES97923382T patent/ES2270460T3/es not_active Expired - Lifetime
- 1997-05-13 ES ES03000391T patent/ES2260524T3/es not_active Expired - Lifetime
-
1998
- 1998-11-13 NO NO19985297A patent/NO325358B1/no not_active IP Right Cessation
-
2006
- 2006-11-02 NO NO20065027A patent/NO325633B1/no not_active IP Right Cessation
-
2009
- 2009-01-07 JP JP2009001597A patent/JP4896999B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2253287A1 (en) | 1997-11-20 |
| WO1997043436A1 (en) | 1997-11-20 |
| JP4896999B2 (ja) | 2012-03-14 |
| EP0934424B1 (de) | 2006-07-26 |
| DE69736391T2 (de) | 2007-08-16 |
| DE69735510T2 (de) | 2006-08-24 |
| AU716245B2 (en) | 2000-02-24 |
| CA2253287C (en) | 2008-02-19 |
| JP2000509994A (ja) | 2000-08-08 |
| NO20065027L (no) | 1999-01-14 |
| EP0934424A1 (de) | 1999-08-11 |
| PT934424E (pt) | 2006-12-29 |
| US5851800A (en) | 1998-12-22 |
| DE69735510D1 (de) | 2006-05-11 |
| DK0934424T3 (da) | 2006-11-20 |
| ATE321141T1 (de) | 2006-04-15 |
| NO985297L (no) | 1999-01-14 |
| NO325633B1 (no) | 2008-06-30 |
| AU2919797A (en) | 1997-12-05 |
| DE69736391D1 (de) | 2006-09-07 |
| NO985297D0 (no) | 1998-11-13 |
| ES2260524T3 (es) | 2006-11-01 |
| PT1318198E (pt) | 2006-08-31 |
| NO325358B1 (no) | 2008-04-07 |
| JP2009148271A (ja) | 2009-07-09 |
| ES2270460T3 (es) | 2007-04-01 |
| NZ332751A (en) | 2000-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE334223T1 (de) | Verfahren zur herstellung eines rekombinanten polypeptids unter hinzufügung eines hemmstoffes einer metallabhängigen protease oder chymotrypsins zum zellkulturmedium | |
| KR960703433A (ko) | 증가된 생물학적 활성을 갖는 끝이 잘린 케라틴세포성장인자(kgf) (a truncated keratinocyte growth factor(kgf) having increased biological activity) | |
| ES8602112A1 (es) | Procedimiento para preparar un polipeptido ciclico | |
| ATE304600T1 (de) | Verfahren zur herstellung von männlich sterilen pflanzen | |
| ATE244307T1 (de) | Rekombinante proteine des filamentoesen haemaglutinins von bordetella,im besonderen bordetella pertusis, herstellungsverfahren und ihre verwendung zur herstellung von fremdproteinen oder vakzinen | |
| US4329430A (en) | Enzyme mixture | |
| DK0832186T3 (da) | Erstatningsterapi til dental caries | |
| US4307081A (en) | Enzyme mixture | |
| DE69625682D1 (de) | Verfahren zur behandlung von entzündungen und zusammensetzungen dafür | |
| ATE92935T1 (de) | Serinproteaseinhibitoren und isolierungsverfahren dazu. | |
| DE69732792D1 (de) | Verfahren zur herstellung parthenokarper oder weiblich-steriler transgener pflanzen | |
| JPH10310534A (ja) | 創傷治療用組成物及びペプチドの使用 | |
| Glyantsev et al. | Crab collagenase in wound debridement | |
| WO1999046368A3 (en) | Carbohydrate-modifying enzymes for burn and wound debridement and methods for treatment | |
| IL90947A (en) | Method for production of hiv protease in transformed cells, dna and vectors comprising said dna used in said production | |
| DE3887856D1 (de) | Methode zur Herstellung von natürlichen, menschlichen Wachstumshormon in reiner Form. | |
| AT404597B (de) | Verfahren zur herstellung von proteinen | |
| AU2007266775B2 (en) | Chymotrypsin from Lucilia sericata larvae and its use for the treatment of wounds | |
| CN107602660A (zh) | 一种蛹虫草多肽制品及其制备方法与应用 | |
| CA1077837A (en) | Hydrolytic enzyme material | |
| SE9300509D0 (sv) | Peg treatment | |
| IE890270L (en) | Proteins derived from human alpha 2 plasmin inhibitor | |
| ATE48531T1 (de) | Verfahren zum sterilisieren von rekombinantem mikroorganismus. | |
| FI102844B1 (fi) | Menetelmä valmistaa parannettu terapeuttisesti aktiivinen kudosplasminogeenin aktivaattori | |
| JPS6427472A (en) | Production of human tissue plasminogen activator and cell strain using therein |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0934424 Country of ref document: EP |